---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-388057"
form_type: "8-K"
ticker: "KMTS"
cik: "0001877184"
company_name: "KESTRA MEDICAL TECHNOLOGIES, LTD."
filed_at: "2026-09-10T21:16:22+00:00"
generated_at: "2026-09-10T21:18:03.623690+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Kestra Medical shareholders elect 3 Class II directors, ratify PwC as auditor

## Summary
- Annual meeting held Sept 9, 2026; 55.4M shares voted (94.53% of outstanding).
- Raymond W. Cohen, Kevin Reilly, Traci S. Umberger elected as Class II directors to 2029 term.
- Cohen received 37.3M for, 10.8M against; Reilly 38.9M for, 9.2M against; Umberger 38.9M for, 9.2M against.
- PwC ratified as independent auditor for FY ending April 30, 2027 with 55.4M for, 8.5K against.

## SEC filing metadata
- accession: 0001193125-26-388057
- form_type: 8-K
- ticker: KMTS
- cik: 0001877184
- company_name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- filed_at: 2026-09-10T21:16:22+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877184/000119312526388057/0001193125-26-388057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877184/000119312526388057/ck0001877184-20260909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-388057
- JSON: https://secwatch.observer/filing/0001193125-26-388057.json
- Plain text: https://secwatch.observer/filing/0001193125-26-388057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
